22.69
price down icon3.08%   -0.72
after-market Dopo l'orario di chiusura: 22.50 -0.19 -0.84%
loading

Catalyst Pharmaceuticals Inc Borsa (CPRX) Ultime notizie

pulisher
Dec 01, 2025

How Do Investors Really Feel About Catalyst Pharmaceuticals Inc? - Benzinga

Dec 01, 2025
pulisher
Dec 01, 2025

Wall Street Analysts Think Catalyst (CPRX) Could Surge 47.37%: Read This Before Placing a Bet - Finviz

Dec 01, 2025
pulisher
Dec 01, 2025

Should Value Investors Buy Catalyst Pharmaceuticals (CPRX) Stock? - Yahoo Finance

Dec 01, 2025
pulisher
Nov 27, 2025

Will Catalyst Pharmaceuticals Inc. stock deliver strong dividend growth2025 Market Trends & Consistent Return Strategy Ideas - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

Will Catalyst Pharmaceuticals Inc. stock see insider buyingGap Down & Weekly High Return Stock Opportunities - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 25, 2025

Here's How Much a $1000 Investment in Catalyst Pharmaceutical Made 10 Years Ago Would Be Worth Today - Yahoo Finance

Nov 25, 2025
pulisher
Nov 24, 2025

Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference - Bakersfield.com

Nov 24, 2025
pulisher
Nov 21, 2025

Will Catalyst Pharmaceuticals Inc. (CN2) stock benefit from sector leadership2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Published on: 2025-11-21 01:33:23 - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 20, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 09:43:10 - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500 - The Globe and Mail

Nov 20, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 03:16:30 - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Catalyst Pharmaceuticals Inc. (CN2) stock is trending on social media2025 Buyback Activity & Daily Profit Maximizing Trade Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Deloitte Fast 500 Ranking Could Be a Game Changer for Catalyst Pharmaceuticals (CPRX) - Sahm

Nov 20, 2025
pulisher
Nov 20, 2025

How Catalyst Pharmaceuticals Inc. (CN2) stock stacks up against competitorsWeekly Market Summary & Fast Momentum Stock Entry Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Relative strength of Catalyst Pharmaceuticals Inc. in sector analysisWeekly Trade Review & Free Technical Confirmation Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What analyst consensus says on Catalyst Pharmaceuticals Inc. stockMarket Movers & Proven Capital Preservation Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why analysts maintain buy rating on Catalyst Pharmaceuticals Inc. (CN2) stockTrend Reversal & Stepwise Swing Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Catalyst Pharmaceuticals Inc. stock is considered a top pickEarnings Overview Summary & Weekly Top Stock Performers List - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock - Yahoo Finance

Nov 19, 2025
pulisher
Nov 19, 2025

Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™ - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

Catalyst Pharmaceuticals (NASDAQ: CPRX) Ranks 304 on 2025 Deloitte Technology Fast 500 - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 04:42:53 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Catalyst Pharmaceuticals Inc. stock attractive for retirement portfoliosInsider Buying & Short-Term Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 00:40:27 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Total assets of Catalyst Pharmaceuticals, Inc. – HAM:CN2 - TradingView

Nov 19, 2025
$39.90
price down icon 0.30%
$102.04
price down icon 2.32%
$31.39
price down icon 3.00%
$97.39
price down icon 5.58%
biotechnology ONC
$335.60
price down icon 1.47%
$211.41
price up icon 1.75%
Capitalizzazione:     |  Volume (24 ore):